We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

18 hedge funds and large institutions have $555K invested in Armata Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

4% more capital invested

Capital invested by funds: $532K → $555K (+$23K)

0.01% less ownership

Funds ownership: 1.65% → 1.64% (-0.01%)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Edgewood Management
Edgewood Management
Connecticut
+$68.9K
2
SWM
SeaCrest Wealth Management
New York
+$43.6K
3
Bank of America
Bank of America
North Carolina
+$10.5K
4
UBS Group
UBS Group
Switzerland
+$5.16K
5
SSB
Sandy Spring Bank
Maryland
+$1.72K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$48K
2
Renaissance Technologies
Renaissance Technologies
New York
-$25.6K
3
BlackRock
BlackRock
New York
-$1.71K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$207K -$25.6K -7,427 -10%
Edgewood Management
2
Edgewood Management
Connecticut
$124K +$68.9K +20,000 +100%
Stifel Financial
3
Stifel Financial
Missouri
$70K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$47K – – –
SWM
5
SeaCrest Wealth Management
New York
$39K +$43.6K +12,655 New
BlackRock
6
BlackRock
New York
$31K -$1.71K -495 -5%
Bank of America
7
Bank of America
North Carolina
$10K +$10.5K +3,055 +30,550%
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$8K – – –
UBS Group
9
UBS Group
Switzerland
$7K +$5.16K +1,498 +192%
Morgan Stanley
10
Morgan Stanley
New York
$6K – – –
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
SSB
12
Sandy Spring Bank
Maryland
$2K +$1.72K +500 New
GWM
13
Geneos Wealth Management
Colorado
$1K – – –
TWA
14
TCI Wealth Advisors
Arizona
$1K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$48K -14,688 Closed
Wells Fargo
16
Wells Fargo
California
– +$76 +22 New
Osaic Holdings
17
Osaic Holdings
Arizona
– +$179 +52 New

ARMP Hedge Fund Activity: Q1 2020 in Review

18 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2020, worth a combined $555K — up 4.3% from $532K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ARMP positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Edgewood Management, adding an estimated $68.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $48K sold.

  • 18 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2020, up from 16 in Q4 2019.
  • Funds reported $555K of Armata Pharmaceuticals stock for Q1 2020, up 4.3% quarter-over-quarter.
  • 4 funds opened new Armata Pharmaceuticals positions in Q1 2020 and 1 closed out, a net change of +3 holders.
  • The largest Armata Pharmaceuticals buyer in Q1 2020 was Edgewood Management, an estimated $68.9K added.
  • The largest Armata Pharmaceuticals seller in Q1 2020 was Susquehanna International Group, an estimated $48K sold.

Based on aggregated 13F filings for Q1 2020.